OCLS

Oculus Innovative Sciences Announces Proposed Public Offering of Common Stock and Intention to Repay Certain Indebtedness

[at noodls] – PETALUMA, Calif., March 6, 2013 (GLOBE NEWSWIRE) — Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) today announced that it intends to offer for sale its common stock in an underwritten public offering. … moreView todays social media effects on OCLSView the latest stocks trending across Twitter. Click to view dashboardSee who Oculus is hiring next, click here to view […]

Oculus Innovative Sciences Strengthens Intellectual Property Portfolio With Issuance of U.S. Patent for Treatment of Skin Ulcers With Microcyn® Technology

[at noodls] – PETALUMA, Calif., Feb. 25, 2013 (GLOBE NEWSWIRE) — Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), a commercial healthcare company that designs, produces and markets innovative, safe and effective drugs, … moreView todays social media effects on OCLSView the latest stocks trending across Twitter. Click to view dashboardSee who Oculus is hiring next, click here to view […]

Oculus Innovative Sciences Reports Revenues of $3.5 Million for the Third Quarter of Fiscal 2013

[at noodls] – Oculus board of directors unanimously approved a plan to spin off the company’s novel drug RUT58-60 as a separate company to be called Ruthigen, Inc. in January 2013 Oculus’ subsidiary, Ruthigen, to pursue … moreView todays social media effects on OCLSView the latest stocks trending across Twitter. Click to view dashboardSee who Oculus is hiring next, click […]

Ruthigen Establishes Independent Headquarters and Targets Public Offering In 2013

[at noodls] – PETALUMA, Calif. and SANTA ROSA, Calif., Jan. 28, 2013 (GLOBE NEWSWIRE) — Ruthigen, Inc., a biopharmaceutical company focused on a unique and new drug candidate, RUT58-60, today announced it has established … moreView todays social media effects on OCLSView the latest stocks trending across Twitter. Click to view dashboardSee who Oculus is hiring next, click here to […]

Oculus Innovative Sciences, Inc. Announces Plan to Spin Off Biotechnology Business

[at noodls] – Oculus Management Conference Call Begins at 4:30 p.m. (ET) Today PETALUMA, Calif., Jan. 10, 2013 (GLOBE NEWSWIRE) — Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) today announced that its board of directors … moreView todays social media effects on OCLSView the latest stocks trending across Twitter. Click to view dashboardSee who Oculus is hiring next, click here to view […]

Oculus Innovative Sciences Strengthens Intellectual Property Portfolio With Issuance of U.S. Patent for Treatment of Skin Ulcers With Microcyn® Technology

[at noodls] – PETALUMA, Calif., Dec. 27, 2012 (GLOBE NEWSWIRE) — Oculus Innovative Sciences, Inc. (Nasdaq: OCLS) a healthcare company that designs, produces and markets innovative, safe and effective anti-infective … moreView todays social media effects on OCLSView the latest stocks trending across Twitter. Click to view dashboardSee who Oculus is hiring next, click here to view […]

In Preparation for European Partnership, Oculus Innovative Sciences Expects Expanded Label Claim for European Formulation of Dermacynâ„¢ Wound Care

[at noodls] – Upgraded Class III CE Mark to Include Claim of Potential Local Antimicrobial Effectiveness in Open Wounds PETALUMA, Calif., Dec. 24, 2012 (GLOBE NEWSWIRE) — Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) … moreView todays social media effects on OCLSView the latest stocks trending across Twitter. Click to view dashboardSee who Oculus is hiring next, click here to view […]

Oculus Innovative Sciences Provides Second Half CY 2012 Business Update

[at noodls] – Cash Position of $8.3 Million at End of Q2 FY 2013 with EBITDAS Loss of $235,000 for First Six Months of FY 2013 Revenues of $8.6 Million for First Half FY 2013 with Product Revenue Growth of 32% Reduction … moreView todays social media effects on OCLSView the latest stocks trending across Twitter. Click to view dashboardSee […]

Oculus Innovative Sciences to Reschedule New York City Financial Analysts Presentation Originally Scheduled for November 5th Due to Impact of Storm Sandy

[at noodls] – Oculus Innovative Sciences to Reschedule New York City Financial Analysts Presentation Originally Scheduled for November 5th Due to Impact of Storm Sandy PETALUMA, Calif., Nov. 2, 2012 (GLOBE NEWSWIRE) … moreView todays social media effects on OCLSView the latest stocks trending across Twitter. Click to view dashboard […]

Oculus Innovative Sciences Reports Record Revenues of $4.5 Million for the Second Quarter of Fiscal 2013

[at noodls] – Oculus Innovative Sciences Reports Record Revenues of $4.5 Million for the Second Quarter of Fiscal 2013 Revenue for the second quarter of $4.5 million, up 24% Revenue for six months of $8.6 million, up … moreView todays social media effects on OCLSView the latest stocks trending across Twitter. Click to view dashboard […]